Cancer Chemotherapy Care Plans Handbook

by Barton-Burke, Margaret

• ISBN13: 9780763714819
• ISBN10: 076371481X
• Edition: 3rd
• Format: Spiral Bound
• Copyright: 2001-10-01
• Publisher: Jones & Bartlett

Summary

This book supplements other oncology nursing textbooks and provides hands-on information to assist the nurse in providing comprehensive care to patients receiving chemotherapy and to their families. The focus of the text is on the chemotherapeutic agents, their side effects, the corresponding nursing diagnoses and care plans, and state methods of administration and handling of these drugs.

Table of Contents

Preface	vii
Acknowledgments	viii
SECTION I Toxicities of Chemotherapy	1	(134)
Common Toxicity Criteria (CTC)	4	(78)
Standardized Nursing Care Plan for Patient Experiencing Bone Marrow Depression	82	(10)
Standardized Nursing Care Plan for Patient Experiencing Nausea and Vomiting	92	(4)
Standardized Nursing Care Plan for Patient Experiencing Stomatitis	96	(8)
Standardized Nursing Care Plan for Patient Experiencing Diarrhea	104	(4)
Potential Hepatotoxicity of Chemotherapeutic Agents	108	(2)
Relative Risks of Chemotherapeutic Agents: Nephrotoxicity	110	(6)
Standardized Nursing Care Plan for Patient Experiencing Alopecia	116	(2)
Standardized Nursing Care Plan for Patient Experiencing Sexual Dysfunction	118	(2)
Drugs That Can Induce Pulmonary Toxicity	120	(4)
Chemotherapeutic Agents Associated with Cardiac Toxicities	124	(4)
Standardized Nursing Care Plan for Patient Experiencing Neuropathy	128	(6)
Nursing Protocol for the Management of Tumor Lysis Syndrome	134	(1)
SECTION II Most Commonly Used Cancer Chemotherapeutic Drugs with Accompanying Care Plans	135	(373)
Anastrozole (Arimidex)	136	(4)
Bicalutamide (Casodex)	140	(4)
Bleomycin Sulfate (Blenoxane)	144	(10)
Busulfan (Myleran)	154	(4)
Busulfan injection (Busulfex)	158	(6)
Capecitabine (Xeloda, N4-pentoxycarbonyl-5-deoxy-5-fluorocytidine)	164	(4)
Carboplatin (Paraplatin)	168	(6)
Carmustine (BiCNU, BCNU)	174	(6)
Chlorambucil (Leukeran)	180	(6)
Cisplatin (Cis-Platinum, CDDP, Platinum, Platinol)	186	(8)
Cladribine (Leustatin, 2-CdA)	194	(6)
Cyclophosphamide (Cytoxan, Endoxan, Endoxana, Neosar)	200	(8)
Cytarabine, cytosine arabinoside (Ara-C, Cytosar-U, Arabinosyl Cytosine)	208	(6)
Cytarabine liposome injection (DepoCyt)	214	(4)
Dacarbazine (DTIC-Dome, Imidazole carboximide)	218	(10)
Dactinomycin (Actinomycin D, Cosmegan)	228	(8)
Daunorubicin hydrochloride (Cerubidine, Daunomycin)	236	(8)
Daunorubicin citrate liposome injection (DaunoXome)	244	(8)
Docetaxel (Taxotere)	252	(10)
Doxorubicin hydrochloride (Adriamycin, Rubex)	262	(8)
Etoposide (VP-16, Vepesid)	270	(10)
Fludarabine phosphate (Fludara, FLAMP)	280	(6)
5-Fluorouracil (Fluorouracil, Adrucil, 5-FU, Efudex [topical])	286	(6)
Flutamide (Eulexin)	292	(4)
Gemcitabine (difluorodeoxycitidine, dFdC)	296	(4)
Hydroxyurea (Hydrea)	300	(6)
Idarubicin (Idamycin, 4-Demethoxydaunorubicin)	306	(8)
Ifosfamide (IFEX)	314	(8)
Irinotecan (Camptosar, Camptothecin-11, CPT-11)	322	(6)
L-asparaginase (ELSPAR)	328	(10)
Leucovorin calcium (Folinic acid, Citrovorum factor)	338	(4)
Melphalan (Alkeran, L-PAM, Phenylalanine Mustard, L-sarcolysin)	342	(10)
6-Mercaptopurine (Purinethol, 6-MP)	352	(6)
Methotrexate (Amethopterin, Mexate, Folex)	358	(8)
Mitoxantrone (Novantrone)	366	(8)
Paclitaxel (Taxol)	374	(12)
Pentostatin (2'-deoxycofomycin, DCF)	386	(8)
Polifeprosan 20 with carmustine (BCNU) implant (Gliadel™)	394	(8)
Tamoxifen citrate (Nolvadex)	402	(4)
Teniposide (Vumon, VM-26)	406	(8)
6-Thioguanine (Thioguanine, Tabloid, 6-TG)	414	(4)
Thiotepa (Triethylene Thiophosphoramide)	418	(6)
Topotecan hydrochloride for injection (Hycamptin)	424	(6)
Vinblastine (Velban)	430	(10)
Vincristine (Oncovin)	440	(8)
Vinorelbine (Navelbine)	448	(20)
APPENDICES
Appendix 1 Chemotherapy Checklist and Nursing Guidelines	468	(17)
1.1 Multidisciplinary Practice Guidelines	469	(5)
1.2 Prechemotherapy Nursing Assessment Guidelines	474	(8)
1.3 Chemotherapy Checklist	482	(3)
Appendix 2 Extravasation	485	(13)
2.1 Vesicants and Irritants	486	(6)
2.2 Standardized Nursing Care Plan for Patient Experiencing Extravasation	492	(4)
2.3 Nursing Assessment of Extravasation versus Other Reactions	496	(2)
Appendix 3 Hypersensitivity and Anaphylactic Reactions	498	(10)
3.1 Types of Hypersensitivity Reactions (Gell and Coombs Classification)	499	(1)
3.2 Summary of Chemotherapy Agents with a High Incidence of Hypersensitivity Reactions	500	(2)
3.3 Management of Hypersensitivity and Anaphylactic Reactions	502	(2)
3.4 Standardized Nursing Care Plan for Patient Experiencing Hypersensitivity or Anaphylaxis	504	(4)
Appendix 4 Illustrated Guide to Handling Cytotoxic and Hazardous Drugs	508